BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8981815)

  • 41. Use of mobile and cordless phones and survival of patients with glioma.
    Hardell L; Carlberg M
    Neuroepidemiology; 2013; 40(2):101-8. PubMed ID: 23095687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors in childhood intracranial neoplasms.
    Ampil FL
    Radiat Med; 1987; 5(6):202-6. PubMed ID: 3452851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracranial tumors in childhood--concepts of treatment and prognosis.
    Schulte FJ
    Neuropediatrics; 1984 Feb; 15(1):3-12. PubMed ID: 6324015
    [No Abstract]   [Full Text] [Related]  

  • 44. Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma.
    Diete S; Treuheit T; Dietzmann K; Schmidt U; Wallesch CW
    J Neurooncol; 2001 May; 53(1):47-9. PubMed ID: 11678430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glioblastoma multiforme.
    Conrad FG; Myers P; Buckley R
    Minn Med; 1969 Mar; 52(3):491-7. PubMed ID: 4307026
    [No Abstract]   [Full Text] [Related]  

  • 46. Management of some intracranial tumors in children and adults.
    Bloom HJ
    Prog Clin Biol Res; 1978; 25():55-84. PubMed ID: 216024
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapeutic results of malignant brain tumors].
    Potthoff PC
    Aktuelle Probl Chir Orthop; 1981; 18():78-86. PubMed ID: 6112901
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of malignant brain tumors by BAR therapy].
    Hoshino T
    No To Shinkei; 1968 Jun; 20(6):601-11. PubMed ID: 4301942
    [No Abstract]   [Full Text] [Related]  

  • 49. Pathologic tumor type and response to treatment.
    Davis RL
    Natl Cancer Inst Monogr; 1977 Dec; 46():83-7. PubMed ID: 206839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Primary cerebral tumors of glial origin. Retrospective study of the last 10 years].
    Martí Cabané J; Antón Aranda E; Pérez C; Labayen F; Martínez Ibáñez F; Maraví Petri E
    Rev Clin Esp; 1984 Sep; 174(6):251-3. PubMed ID: 6097958
    [No Abstract]   [Full Text] [Related]  

  • 51. [Survival analysis for high-grade glioma patients who received comprehensive treatment].
    Liu G; Jiang R; Xu C; Zhou J; Liu F; He Z; Liu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):388-393. PubMed ID: 29774874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Blood groups and brain tumors].
    Alcantara A; Kinzel W; Bube FW; Uhlenbruck G
    Zentralbl Neurochir; 1965; 26(2):156-65. PubMed ID: 4284594
    [No Abstract]   [Full Text] [Related]  

  • 53. Histological investigations of brain tumours treated by combined therapy.
    Slowik F
    Minerva Neurochir; 1969; 13(3):260-4. PubMed ID: 4315380
    [No Abstract]   [Full Text] [Related]  

  • 54. [Advances in the treatment of brain tumors in childhood].
    Muñoz Villa A; Bustos JC; Martínez V; Martínez-Pardo M; Madero L
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():76-8. PubMed ID: 6318621
    [No Abstract]   [Full Text] [Related]  

  • 55. Referral patterns of childhood brain tumors in the state of Connecticut.
    Duffner PK; Cohen ME; Flannery JT
    Cancer; 1982 Oct; 50(8):1636-40. PubMed ID: 6288221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P; Lapras C
    Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
    [No Abstract]   [Full Text] [Related]  

  • 57. Retreatment of intracranial gliomas.
    Landy HJ; Feun L; Schwade JG; Snodgrass S; Lu Y; Gutman F
    South Med J; 1994 Feb; 87(2):211-4. PubMed ID: 8115886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Incidence of glioblastoma multiforme in Aragon and La Rioja. An epidemiological survey].
    Monzón MJ; Pascual-Piazuelo MC; López-López A; Calatayud V; Eiras J
    Rev Neurol; 1996 Jan; 24(125):73-6. PubMed ID: 8852004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.
    Davis FG; Freels S; Grutsch J; Barlas S; Brem S
    J Neurosurg; 1998 Jan; 88(1):1-10. PubMed ID: 9420066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry.
    Mathiesen T; Peredo I; Lönn S
    Acta Neurochir (Wien); 2011 Mar; 153(3):467-71. PubMed ID: 21161295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.